Spero Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | — | $46.4M |
| Sep 2017 | $7.3M | $31.6M | $25.4M |
| Dec 2017 | $8.5M | $93.5M | $87.3M |
| Mar 2018 | $6.2M | $81.1M | $52.6M |
| Jun 2018 | $6.9M | $72.6M | $48.7M |
| Sep 2018 | $10.6M | $136.1M | $40.5M |
| Dec 2018 | $13.2M | $129.0M | $34.1M |
| Mar 2019 | $11.3M | $124.7M | $49.4M |
| Jun 2019 | $12.8M | $122.5M | $71.1M |
| Sep 2019 | $19.5M | $112.5M | $45.6M |
| Dec 2019 | $31.5M | $106.1M | $29.7M |
| Mar 2020 | $27.5M | $109.9M | $64.4M |
| Jun 2020 | $23.8M | $97.5M | $65.3M |
| Sep 2020 | $24.3M | $157.0M | $125.2M |
| Dec 2020 | $21.4M | $153.5M | $85.2M |
| Mar 2021 | $24.6M | $143.4M | $77.0M |
| Jun 2021 | $29.3M | $119.6M | $71.6M |
| Sep 2021 | $32.8M | $144.7M | $112.9M |
| Dec 2021 | $82.8M | $171.1M | $112.6M |
| Mar 2022 | $83.4M | $145.8M | $72.1M |
| Jun 2022 | $27.7M | $63.6M | $45.4M |
| Sep 2022 | $32.0M | $64.5M | $50.4M |
| Dec 2022 | $48.9M | $124.8M | $109.1M |
| Mar 2023 | $47.7M | $112.5M | $96.3M |
| Jun 2023 | $44.1M | $98.9M | $77.7M |
| Sep 2023 | $53.4M | $107.1M | $93.8M |
| Dec 2023 | $75.5M | $182.4M | $76.3M |
| Mar 2024 | $71.5M | $167.7M | $82.3M |
| Jun 2024 | $69.4M | $149.9M | $63.5M |
| Sep 2024 | $69.7M | $135.2M | $76.3M |
| Dec 2024 | $64.4M | $110.5M | $52.9M |
| Mar 2025 | $43.9M | $77.7M | $48.9M |
| Jun 2025 | $29.3M | $62.1M | $31.2M |
| Sep 2025 | $27.7M | $54.2M | $48.6M |
| Dec 2025 | $9.9M | $68.9M | $40.3M |
| Mar 2026 | $6.1M | $59.0M | $56.1M |
| Jun 2026 | $8.6M | $52.8M | $50.8M |